Navigation Links
CryoCor Reports 2007 Results
Date:3/20/2008

ssfully commercialized, they anticipate that their cost of sales as a percentage of revenues will decline as they achieve higher future volumes of product sales. Included in cost of sales for the years ended December 31, 2007 and 2006 were non-cash stock-based compensation of $431,000 and $411,000, respectively.

Research and development expenses for the year ended December 31, 2007 increased $1.6 million to $7.4 million compared to $5.8 million for the same period in 2006. The increase from 2006 to 2007 was primarily related to the costs associated with its FDA Advisory Panel meeting for its PMA for the treatment of atrial flutter, or AFL, and related regulatory consulting of $276,000, costs related to the Company's third-party clinical research organization of $403,000, costs related to the research and development efforts under the BSC development and license agreement and the Quantum development project of $382,000, increased preclinical research of $225,000, increased non-cash share-based compensation of $185,000, as well as increased compensation expense for bonus expense related to the Company's FDA Advisory Panel meeting and subsequent approval of its Cardiac Cryoablation System for the treatment of AFL and the Company's employee retention program of $503,000. These increases were partially offset by lower clinical trial costs of $261,000 related to lower enrollment in the Company's ongoing AF clinical trial than enrollment in the year ended December 31, 2006. Included in research and development expenses for the years ended December 31, 2007 and 2006 were non-cash stock-based compensation of $682,000 and $497,000, respectively.

Selling, general and administrative expenses for the year ended December 31, 2007 decreased $1.3 million to $6.1 million compared to $7.4 million for the same period in 2006. The decrease from 2006 to 2007 was primarily due to lower personnel costs, including severance, as a result of the Company's staff restructuring in
'/>"/>

SOURCE CryoCor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. CryoCor Announces Web cast and Conference Call of 2007 Year End Results
2. CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
3. Dr. Warren Jackman Joins CryoCor Scientific Advisory Board
4. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
5. CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation
6. CryoCor Files Response to Patent Infringement Lawsuit
7. CryoCor Announces Web cast and Conference Call of Third Quarter 2007 Results
8. CryoCor Appoints New Vice President of Sales and Marketing
9. CryoCor to Present at Maxim Group First Annual Growth Conference in New York
10. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
11. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... 2014) Two recent papers by a University ... may help scientists develop treatments or vaccines for ... encephalitis and other disease-causing flaviviruses. , Jeffrey S. ... genetics at the School of Medicine and an ... Institute, and colleagues recently published articles in the ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
(Date:4/17/2014)... NY, April 17, 2014U.S. military personnel who served ... impact" concussive traumatic brain injury (TBI) were compared ... for other medical reasons. Differences in measures of ... 6-12 months after injury are reported in an ... peer-reviewed journal from Mary Ann Liebert, Inc., publishers. ...
(Date:4/17/2014)... many as 10 million older Americans suffer from depression, ... , However, new research a project that followed ... six years found that Internet use among the ... than 30 percent. , "That,s a very strong effect," ... telecommunication, information studies and media who led the project. ...
(Date:4/17/2014)... CHICAGO, IL, April 17, 2014-- Colic affects about one ... accounts for numerous pediatric visits during the first several ... of colic symptoms was showing promise; however, the April ... (BMJ2014;348:g2107; Sung, Valerie) reported on a study, "Probiotics ... probiotic L reuteri for infant colic ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... H. Werren will give the 2011 Alfred M. Boyce Lecture ... His lecture, titled "Using Nasonia (and its microbes) to ... p.m. in the Genomics Auditorium, Room 1102A, Genomics Building , ... of Entomology lobby. Both the talk and reception are free ...
... WEDNESDAY, May 11 (HealthDay News) -- The flakes of human ... according to new research. Humans shed their entire outer ... pointed out in the study, published in the May issue ... flakes, which contain skin oils such as cholesterol and squalene, ...
... (HealthDay News) -- Infants, sleep patterns can be disrupted if ... a new study finds. In addition, infants who heard ... continued to have troubled sleep patterns -- marked by problems ... were 18-month-old toddlers. The researchers found, however, that ...
... one of the highest mortality rates of any of the major ... year, more than 94 percent die within five years of diagnosis. ... of effective screening tools for catching the disease early. Now, in ... deadly form of cancer, Mayo Clinic researchers believe they have found ...
... of three promising formulations that could be used in a ... serious drug abuse problems in the U.S. The report appears ... In the paper, Kim Janda and colleagues note that ... billion annually due to medical and law enforcement expenses, as ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... as erythropoietin alfa after a heart attack may experience new ... a new study finds. The drug, which stimulates red ... because certain studies suggested it might reduce the extent of ...
Cached Medicine News:Health News:Evolutionary geneticist to give talk at UC Riverside on how biological species evolve and adapt 2Health News:Shed Skin in Dust May Reduce Indoor Air Pollution 2Health News:Parents' Fighting Can Even Affect Infants: Study 2Health News:Mayo Clinic reports new findings on noninvasive test for pancreatic cancer 2Health News:Anemia Drug May Worsen Heart Attacks 2Health News:Anemia Drug May Worsen Heart Attacks 3
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led ... a premier and affordable laser tattoo removal experience with ... Brandeis, focus is in providing high quality cosmetic services with cutting ... " Southern California has seen a ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre ... Leesburg, Virginia is the first in Loudoun ... Dr. Susan M. Barnes , Medical Director, ... and husband, Dr. Cole Taylor , are avid scuba divers. ...
(Date:1/14/2014)... , Jan. 14, 2014   Oligomerix, Inc. , a ... therapeutics for Alzheimer,s disease (AD) and related neurodegenerative disorders, ... Valhalla, NY as of January ... space at New York Medical College. Oligomerix, ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... ANTONIO, Feb. 28, 2011 Advanced Cell Diagnostics, ... clinical study utilizing RNAscope™ technology to detect human ... of head and neck cancer. HPV status determined ... of patient outcome and highly concordant with that ...
... 2011 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) ... dividend policy for 2011 and beyond and declared that the four ... be $0.15 per share of common stock.  The $0.15 dividends will ... 15 to all stockholders who own shares of PDL on March ...
Cached Medicine Technology:ACD Announces Clinical Study Results Using its RNAscope™ Technology 2ACD Announces Clinical Study Results Using its RNAscope™ Technology 3PDL BioPharma Announces Regular Quarterly Dividend Policy 2
... SST™ Tubes contain spray-coated ... gel for serum separation. ... serum determinations in chemistry. ... efficient means of serum ...
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry....
MONOJECT Red/Yellow Mottled Stopper...
BD Vacutainer® Specialty Tubes - Thrombin...
Medicine Products: